Zobrazeno 1 - 10
of 87
pro vyhledávání: '"DCM, Dilated cardiomyopathy"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
ESC Heart Failure, Vol 7, Iss 4, Pp 1909-1916 (2020)
Abstract Aims Hypokinetic non‐dilated cardiomyopathy (HNDC), which is determined by impaired left ventricular (LV) systolic function despite normal LV size, has been categorized as a subgroup of dilated cardiomyopathy (DCM) spectrum. Lack of data r
Externí odkaz:
https://doaj.org/article/c0c2c93bcc744569b113be1c02c05585
Publikováno v:
JACC: Basic to Translational Science
Highlights • Knowledge of the genetic etiologies of cardiomyopathies has created novel opportunities for treatments. • Emerging treatments targets include gene therapy, myofilament function, protein quality control, and metabolism. • Considerat
Autor:
Birgitta K. Velthuis, Arco J. Teske, Dennis Bosboom, Reinder Evertz, Rob W Roudijk, Floris E A Udink Ten Cate, Carlo Marcelis, Anneline S.J.M. te Riele
Publikováno v:
JACC Case Reports
JACC: Case Reports, Vol 2, Iss 6, Pp 919-924 (2020)
JACC: Case Reports, Vol 2, Iss 6, Pp 919-924 (2020)
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is rarely diagnosed in childhood. We describe the case of a 9-year-old girl with genetically confirmed ARVC who presented with syncope, ventricular arrhythmia, and biventricular myocardial dysfun
Autor:
Felix Maverick R. Uy, Phong Teck Lee, Calvin W. L. Chin, Jie Sheng Foo, Thu-Thao Le, Ju Le Tan
Publikováno v:
JACC: Case Reports, Vol 2, Iss 5, Pp 740-744 (2020)
JACC Case Reports
JACC Case Reports
We report a case of coronary artery compression and athlete's heart in a patient with a history of transposition of the great arteries. We present the diagnostic dilemmas and demonstrate the use of cardiac magnetic resonance imaging and cycle-ergomet
Autor:
R. Mohan, T. Muralikrishna, R. Veena, K.G. Sureshrao, A. Ajay, K. Ramasubramanian, D. Jagdish, R. Ravikumar, K. Ganapathy Subramaniam, Komarakshi Balakrishnan
Publikováno v:
Indian Heart Journal, Vol 72, Iss 6, Pp 524-534 (2020)
Indian Heart Journal
Indian Heart Journal
Objective: End stage heart failure is a lethal disease with a dismal 5 year survival. Heart transplantation has proven to be a highly effective modality of treatment in appropriately selected group of such patients. This is a retrospective analysis o
Publikováno v:
JACC: CardioOncology
Background Adriamycin-associated cardiomyopathy (ACM) can lead to end-stage heart failure requiring advanced heart failure therapies. Objectives This study sought to provide post–cardiac transplant survival data in patients with ACM in the contempo
Autor:
Clarissa P.C. Gomes, Yvan Devaux, Esther E. Creemers, Christoph Dieterich, Antonio Salgado-Somoza, Mitja Luštrek
Publikováno v:
Non-coding RNA Research
Non-coding RNA Research, Vol 3, Iss 1, Pp 1-11 (2018)
Non-coding RNA Research, Vol 3, Iss 1, Pp 1-11 (2018)
Until recently considered as rare, circular RNAs (circRNAs) are emerging as important regulators of gene expression. They are ubiquitously expressed and represent a novel branch of the family of non-coding RNAs. Recent investigations showed that circ
Autor:
Linnea M, Baudhuin
Publikováno v:
Journal of the American College of Cardiology
Background Hypertrophic cardiomyopathy (HCM) is caused by rare variants in sarcomere-encoding genes, but little is known about the clinical significance of these variants in the general population. Objectives The goal of this study was to compare lif
Autor:
Yukako Domoto, Yumiko Hosoya, Masamichi Ito, Toshiyuki Ko, Hiroyuki Morita, Yukari Uemura, Takashige Tobita, Shintaro Yamada, Masaru Hatano, Kanna Fujita, Issei Komuro, Seitaro Nomura, Eisuke Amiya, Masashi Fukayama, Manami Katoh, Masahiro Satoh, Hiroyuki Aburatani
Publikováno v:
JACC: Basic to Translational Science
JACC: Basic to Translational Science, Vol 4, Iss 6, Pp 670-680 (2019)
JACC: Basic to Translational Science, Vol 4, Iss 6, Pp 670-680 (2019)
Visual Abstract
Highlights • Patients with dilated cardiomyopathy who achieved LVRR have a favorable prognosis, but it is still difficult to precisely predict LVRR in the clinical setting. • Immunostaining of DNA damage markers such as PAR i
Highlights • Patients with dilated cardiomyopathy who achieved LVRR have a favorable prognosis, but it is still difficult to precisely predict LVRR in the clinical setting. • Immunostaining of DNA damage markers such as PAR i